Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct-acting antiviral agents.

MLA

Ohama, Hideko, et al. “Changes in Clinical Outcomes in Japanese Patients with Hepatocellular Carcinoma Due to Hepatitis C Virus Following the Development of Direct-Acting Antiviral Agents.” Journal of Gastroenterology and Hepatology, vol. 39, no. 7, July 2024, pp. 1394–402. EBSCOhost, https://doi.org/10.1111/jgh.16553.

APA

Ohama, H., Hiraoka, A., Tada, T., Kariyama, K., Itobayashi, E., Tsuji, K., Ishikawa, T., Toyoda, H., Hatanaka, T., Kakizaki, S., Naganuma, A., Tada, F., Tanaka, H., Nakamura, S., Nouso, K., Tanaka, K., & Kumada, T. (2024). Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct-acting antiviral agents. Journal of Gastroenterology and Hepatology, 39(7), 1394–1402. https://doi.org/10.1111/jgh.16553

Chicago

Ohama, Hideko, Atsushi Hiraoka, Toshifumi Tada, Kazuya Kariyama, Ei Itobayashi, Kunihiko Tsuji, Toru Ishikawa, et al. 2024. “Changes in Clinical Outcomes in Japanese Patients with Hepatocellular Carcinoma Due to Hepatitis C Virus Following the Development of Direct-Acting Antiviral Agents.” Journal of Gastroenterology and Hepatology 39 (7): 1394–1402. doi:10.1111/jgh.16553.